Koyfin Home > Directory > Health Care > Replimune Group Inc > Net Debt / (EBITDA-CAPEX)

Replimune Group Inc Net Debt / (EBITDA-CAPEX) Chart (REPL)

Replimune Group Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2017 to 2020.
  • Replimune Group Inc Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $3m a 41.31% increase of 1m year over year
  • Replimune Group Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $3m a 34.47% increase of 1m year over year
  • Replimune Group Inc Annual Net Debt / (EBITDA-CAPEX) for 2020 was $2m a -86.68% decrease of -2m from 2019
  • Replimune Group Inc Annual Net Debt / (EBITDA-CAPEX) for 2019 was $4m a 12.79% increase of 1m from 2018
  • Replimune Group Inc Annual Net Debt / (EBITDA-CAPEX) for 2018 was $4m a 31.69% increase of 1m from 2017
Other Ratios Metrics:
  • Replimune Group Inc Total Debt / Capital for the quarter ending December 12, 2018 was $3m
  • Replimune Group Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a 69.05% increase of 0m year over year
  • Replimune Group Inc Total Debt / Equity for the quarter ending December 12, 2018 was $3m
View Chart On Koyfin

Quarterly REPL Net Debt / (EBITDA-CAPEX) Data

06/2020$3m
03/2020$2m
12/2019$2m
09/2019$2m
06/2019$3m
03/2019$4m
12/2018$4m
09/2018$5m
06/2018$2m
03/2018$2m

Annual REPL Net Debt / (EBITDA-CAPEX) Data

2020$2m
2019$4m
2018$4m
2017$2m